Autism and cancer evidence scan finds no qualifying causal breakthrough
No robust new replicated autism-causation finding or major cancer trial meeting GIB's evidentiary standard was released in the reporting window. No single autism cause has been established, and no new treatment should be described as a cancer cure.
Central finding
- No qualifying replicated autism-causation result was identified.
- No qualifying cancer cure was verified.
Evidence and limits
This is a bounded evidence scan rather than proof that no unpublished or inaccessible research exists.
- Evidence searches are constrained by publication timing and access.
Why it matters
Patients and families are harmed when preliminary associations or limited treatment results are promoted as established causes or cures.
What changed
No result crossed the publication threshold during the window.
What comes next
Replicated causal studies, preregistered trials, FDA actions, and mature survival or functional-outcome data.
U.S. strategic assessment
High interestPatients and families are harmed when preliminary associations or limited treatment results are promoted as established causes or cures.
Objectives
- Protect U.S. security, economic resilience, and citizens using measurable, lawful action.
Strategy
- Use primary records, allied coordination, market evidence, and independent verification to distinguish action from rhetoric.
Outcomes
- No result crossed the publication threshold during the window.
Risks
- Evidence searches are constrained by publication timing and access.
Sources
01Primary record